| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |